Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Biomol Struct Dyn ; 36(8): 2147-2162, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28627969

RESUMO

Fasciola gigantica is the causative organism of fascioliasis and is responsible for major economic losses in livestock production globally. F. gigantica thioredoxin1 (FgTrx1) is an important redox-active enzyme involved in maintaining the redox homeostasis in the cell. To identify a potential anti-fasciolid compound, we conducted a structure-based virtual screening of natural compounds from the ZINC database (n = 1,67,740) against the FgTrx1 structure. The ligands were docked against FgTrx1 and 309 ligands were found to have better docking score. These compounds were evaluated for Lipinski and ADMET prediction, and 30 compounds were found to fit well for re-docking studies. After refinement by molecular docking and drug-likeness analysis, three potential inhibitors (ZINC15970091, ZINC9312362, and ZINC9312661) were identified. These three ligands were further subjected to molecular dynamics simulation (MDS) to compare the dynamics and stability of the protein structure after binding of the ligands. The binding free energy analyses were calculated to determine the intermolecular interactions. The results suggested that the two compounds had a binding free energy of -82.237, and -109.52 kJ.mol-1 for compounds with IDs ZINC9312362 and ZINC9312661, respectively. These predicted compounds displayed considerable pharmacological and structural properties to be drug candidates. We concluded that these two compounds could be potential drug candidates to fight against F. gigantica parasites.


Assuntos
Produtos Biológicos/química , Proteínas de Helminto/química , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Tiorredoxinas/química , Sequência de Aminoácidos , Animais , Produtos Biológicos/metabolismo , Produtos Biológicos/farmacologia , Avaliação Pré-Clínica de Medicamentos , Fasciola/genética , Fasciola/metabolismo , Proteínas de Helminto/antagonistas & inibidores , Proteínas de Helminto/metabolismo , Ligantes , Estrutura Molecular , Ligação Proteica , Domínios Proteicos , Homologia de Sequência de Aminoácidos , Termodinâmica , Tiorredoxinas/antagonistas & inibidores , Tiorredoxinas/metabolismo
2.
J Cell Biochem ; 119(4): 3067-3080, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29052925

RESUMO

Fascioliasis is caused by the helminth parasites of genus Fasciola. Thioredoxin glutathione reductase (TGR) is an important enzyme in parasitic helminths and plays an indispensable role in its redox biology. In the present study, we conducted a structure-based virtual screening of natural compounds against the Fasciola gigantica TGR (FgTGR). The compounds were docked against FgTGR in four sequential docking modes. The screened ligands were further assessed for Lipinski and ADMET prediction so as to evaluate drug proficiency and likeness property. After refinement, three potential inhibitors were identified that were subjected to 50 ns molecular dynamics simulation and free energy binding analyses to evaluate the dynamics of protein-ligand interaction and the stability of the complexes. Key residues involved in the interaction of the selected ligands were also determined. The results suggested that three top hits had a negative binding energy greater than GSSG (-91.479 KJ · mol-1 ), having -152.657, -141.219, and -92.931 kJ · mol-1 for compounds with IDs ZINC85878789, ZINC85879991, and ZINC36369921, respectively. Further analysis showed that the compound ZINC85878789 and ZINC85879991 displayed substantial pharmacological and structural properties to be a drug candidate. Thus, the present study might prove useful for the future design of new derivatives with higher potency and specificity.


Assuntos
Antiplatelmínticos/química , Inibidores Enzimáticos/química , Fasciola/enzimologia , Complexos Multienzimáticos/química , NADH NADPH Oxirredutases/química , Animais , Antiplatelmínticos/farmacologia , Sítios de Ligação , Simulação por Computador , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/farmacologia , Fasciola/efeitos dos fármacos , Proteínas de Helminto/química , Modelos Moleculares , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Estrutura Molecular , Complexos Multienzimáticos/antagonistas & inibidores , NADH NADPH Oxirredutases/antagonistas & inibidores , Análise de Componente Principal , Multimerização Proteica , Homologia Estrutural de Proteína
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA